Skip to main content
Caplight Logo









Bertis

Bertis

Private
Seongnam-siHealthcare & Life Scienceshttps://bertis.com/

Last Round

Private Equity

Feb 26, 2024

Est. Valuation

$109.56M

Total Funding Raised

$53.73M

Company Overview

Bertis is a biotechnology company that develops proteomics-based precision medicine technology and AI-driven diagnostic solutions for cancer and other major diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Drug Discovery, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

proteomicsearly cancer detectionliquid biopsyprecision medicinebiomarker discoverymulti-omicsmedical AImass spectrometrydiagnostic testdrug target discoverybioinformaticsclinical diagnosticscancer screeningAI diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bertis Comparables

Compare Bertis with similar companies based on industry and business-model similarity.

Bertis comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bcal Diagnostics Ltd
77%
PrognomiQ
77%
Illumina, Inc.
76%

Bertis Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityFeb 26, 2024
Corporate FundingJun 3, 2021
Series BDec 28, 2020
Series AOct 31, 2018

Key People

Founding team and executive leadership

Jayden P.

Chief Financial Officer & Co-founder

Founding Team

dong-young noh

Chief Executive Officer

Executive Team

Seungman Han

Chief Executive Officer

Executive Team

Bertis Investors

Notable investors and investment history

Bertis investors
InvestorRounds
BNH INVESTMENTSeries B, Private Equity
Smilegate InvestmentSeries B, Series A
Focus Assets ManagementSeries B
KCLAVIS InvestmentSeries B
Korea Investment PartnersSeries A
Winvest Venture CapitalPrivate Equity
Premier PartnersSeries B, Private Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 2, 2025

    Monthly visitors increased 58% MoM, reaching 1.4K.

  • Apr 9, 2025

    Monthly visitors grew 371% MoM, reaching 885.

Bertis Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Bertis Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Bertis's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeongnam-si
Employee Range37
Year Founded2014
Last FundingFeb 26, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?